Neuroanatomical Study of In-Vivo Brainstem Abnormalities in Autism Spectrum Disorder and Their Clinical Correlations
DOI:
https://doi.org/10.36283/ziun-pjmd14-3/039Keywords:
Autism, Propionic Acid , Brainstem, In-vivo, Neuroanatomy, Rat Model, HistopathologyAbstract
Background: Autism Spectrum Disorder (ASD) is typically linked to dysfunction of the brainstem, interfering with sensory treatment and autonomic management. The study aimed at examining the structural changes in the brainstem of a rat model induced by propionic acid (PPA) and focused on neuroanatomy changes within the medulla and pons.
Methods: This in vivo study of 6 months (June 2023- December 2023) was carried out in the department of Anatomy at LUMHS Jamshoro. Twenty Wistar male rats were also divided into two groups. control (Group A n = 6) and PPA provoke an autism spectrum disorder (ASD) model (Group B n = 14). The groups were assigned using a random sampling technique. The animals were induced with ASD-like behaviors using oral administration of 250 mg/kg PPA for 5 consecutive days. The open field and social interaction tests were used to conduct behavioral assessments. brainstems were dissected after euthanasia for histopathological analysis, where morphometric evaluation of thickness and densities of the brainstem, and vascular changes were observed. Statistical analysis was run on SPSS version 26, p <0.05 as a significance level(T-test).
Results: PPA-treated rats showed significantly reduced brainstem thickness in the pons (1.10 ± 0.06 mm vs. 1.35 ± 0.08 mm, p < 0.001) and medulla (0.98 ± 0.05 mm vs. 1.22 ± 0.07 mm, p < 0.001), with severe neuronal loss (83%) and vascular congestion (91%). Behavioral scores declined, including reduced locomotor activity (392 ± 70 cm vs. 610 ± 85 cm, p < 0.01) and social interaction (3.2 ± 0.9 vs. 7.1 ± 1.0, p < 0.001).
Conclusion: This study has demonstrated that PPA-induced ASD triggers structural changes in the brainstem, namely in the medulla and pons, giving hints on the neuroanatomical changes involved in ASD and possible therapeutic options for the medulla and pons.
References
1. Dadalko OI, Travers BG. Evidence for Brainstem Contributions to Autism Spectrum Disorders. Front Integr Neurosci. 2018 Oct; 12. doi:10.3389/fnint.2018.00047
2. Seif A, Shea C, Schmid S, Stevenson RA. A Systematic Review of Brainstem Contributions to Autism Spectrum Disorder. Front Integr Neurosci. 2021 Nov; 15. doi:10.3389/fnint.2021.760116
3. El-Ansary AK, Bacha AB, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation. 2012 Apr; 9(1):74. doi:10.1186/1742-2094-9-74
4. Sharma AR, Batra G, Saini L, Sharma S, Mishra A, Singla R, et al. Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure. CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders). 2022 Jun; 21(5):399-408. doi:10.2174/1871527320666210806165430
5. Abdelli LS, Samsam A, Naser SA, Mishra A, Singla R. Propionic Acid Induces Gliosis and Neuro-inflammation through Modulation of PTEN/AKT Pathway in Autism Spectrum Disorder. Sci Rep. 2019 Jun;9(1):8824. doi:10.1038/s41598-019-45348-z
6. Witters P, Debbold E, Crivelly K, et al. Autism in patients with propionic acidemia. Molecular Genetics and Metabolism. 2016 Dec; 119(4):317-321. doi:10.1016/j.ymgme.2016.10.009
7. MacFabe DF, Cain DP, Rodriguez-Capote K, et al. Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behavioural Brain Research. 2007 Jan; 176(1):149-169. doi:10.1016/j.bbr.2006.07.025
8. Aldbass AM, Bhat RS, El-Ansary A. Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. J Neuroinflammation. 2013 Mar; 10(1):837. doi:10.1186/1742-2094-10-42
9. Fluegge K. Propionic acid metabolism, ASD, and vitamin B12: Is there a role for environmental nitrous oxide? International Journal of Developmental Neuroscience. 2017 Apr; 57:21-23. doi:10.1016/j.ijdevneu.2016.12.007
10. Thomas RH, Meeking MM, Mepham JR, Tichenoff L, Possmayer F, Liu S. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation. 2012 Jul; 9(1):153. doi:10.1186/1742-2094-9-153
11. Shchelochkov OA, Farmer CA, Chlebowski C, Adedipe, Ferry S, Manoli I, et al. Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology. Mol Psychiatry. 2024 Jan; 29(4):974-981. doi:10.1038/s41380-023-02385-5
12. de la Bâtie CD, Barbier V, Roda C, Brassier A, Arnoux J, Valayannopoulos V, et al. Autism spectrum disorders in propionic acidemia patients. J Inherit Metab Dis. 2018 Aug; 41(4):623-629. doi:10.1007/s10545-017-0070-2
13. Alsubaiei SRM, Alfawaz HA, Bhat RS, El-Ansary A. Nutritional Intervention as a Complementary Neuroprotective Approach against Propionic Acid-Induced Neurotoxicity and Associated Biochemical Autistic Features in Rat Pups. Metabolites. 2023 Jul; 13(6):738. doi:10.3390/metabo13060738
14. Mirza R, Sharma B. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress. Chemico-Biological Interactions. 2019 Sep; 311:108758. doi:10.1016/j.cbi.2019.108758
15. Hu T, Dong Y, He C, Zhao M, He Q. The Gut Microbiota and Oxidative Stress in Autism Spectrum Disorders (ASD). Oxidative Medicine and Cellular Longevity. 2020 Oct; 2020(1):8396708. doi:10.1155/2020/8396708
16. Frye RE, Rose S, Chacko J, Wynne R, Bennuri S, Slattery J, et al. Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. Transl Psychiatry. 2016 Oct; 6(10):e927-e927. doi:10.1038/tp.2016.189
17. Erten F. Lycopene ameliorates propionic acid-induced autism spectrum disorders by inhibiting inflammation and oxidative stress in rats. Journal of Food Biochemistry. 2021 Sep; 45(10):e13922. doi:10.1111/jfbc.13922
18. El-Ansary A, Al-Ayadhi L. Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autism. Lipids Health Dis. 2014 Aug; 13(1):140. doi:10.1186/1476-511X-13-140
19. Morton PD, Ishibashi N, Jonas RA. Neurodevelopmental Abnormalities and Congenital Heart Disease. Circulation Research. 2017 Mar; 120(6):960-977. doi:10.1161/CIRCRESAHA.116.309048
20. Xiao Z, Qiu T, Ke X, Xiao X, Xiao T, Liang F, et al. Autism Spectrum Disorder as Early Neurodevelopmental Disorder: Evidence from the Brain Imaging Abnormalities in 2–3 Years Old Toddlers. J Autism Dev Disord. 2014 Jan; 44(7):1633-1640. doi:10.1007/s10803-014-2033-x
21. Macfabe D. Autism: Metabolism, Mitochondria, and the Microbiome. Glob Adv Health Med. 2013 Nov; 2(6):52-66. doi:10.7453/gahmj.2013.089
22. MacFabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microbial Ecology in Health and Disease. 2012 Aug; 23(1):19260. doi:10.3402/mehd.v23i0.19260
23. Meeking MM, MacFabe DF, Mepham JR, Foley K, Tichenoff L, Bron F, et al. Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2020 Mar; 97:109794. doi:10.1016/j.pnpbp.2019.109794
24. Alonazi M, Bacha AB, Suhaibani AA, Almnaizel AT, Aloudah HS, El-Ansary A. Psychobiotics improve propionic acid-induced neuroinflammation in juvenile rats, rodent model of autism. Translational Neuroscience. 2022 Sep; 13(1):292-300. doi:10.1515/tnsci-2022-0226
25. Al-Owain M, Kaya N, Al-Shamrani H, et al. Autism Spectrum Disorder in a Child with Propionic Acidemia. In: Brown G, Morava E, Peters V, Gibson KM, Zschocke J, eds. JIMD Reports - Case and Research Reports, 2012/4. Springer; 2013 Jan:63-66. doi:10.1007/8904_2012_143
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
